| 臺大學術典藏 |
2021-08-31T06:29:36Z |
Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Liang P.-C.; Hsu C.; Hsu C.-H.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-08-31T06:29:25Z |
Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer
|
Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; Chen T.W.-W.; Wei S.-Y.; ANN-LII CHENG; Shih T.T.-F. |
| 臺大學術典藏 |
2021-07-26T10:01:06Z |
Long-term nanoplastics exposure results in multi and trans-generational reproduction decline associated with germline toxicity and epigenetic regulation in Caenorhabditis elegans
|
Yu C.-W;Luk T.C;Liao V.H.-C.; Yu C.-W; Luk T.C; Liao V.H.-C.; VIVIAN LIAO |
| 臺大學術典藏 |
2021-07-26T09:45:05Z |
A highly HDAC6-selective inhibitor acts as a fluorescent probe
|
Ho Y.-H;Wang K.-J;Hung P.-Y;Cheng Y.-S;Liu J.-R;Fung S.-T;Liang P.-H;Chern J.-W;Yu C.-W.; Ho Y.-H; Wang K.-J; Hung P.-Y; Cheng Y.-S; Liu J.-R; Fung S.-T; Liang P.-H; Chern J.-W; Yu C.-W.; JE-RUEI LIU |
| 臺大學術典藏 |
2021-07-26T09:45:04Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng C;Li Y.-H;Yu C.-W;Cheng Z.-H;Liu J.-R;Hsu J.-L;Hsin L.-W;Huang C.-T;Juan H.-F;Chern J.-W;Cheng Y.-S.; Peng C; JE-RUEI LIU et al. |
| 臺大學術典藏 |
2021-07-07T05:13:07Z |
Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease
|
Yu C.-W.; Chang P.-T.; LING-WEI HSIN; Chern J.-W. |
| 臺大學術典藏 |
2021-07-07T05:13:04Z |
High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
|
Liu J.-R.;Yu C.-W.;Hung P.-Y.;Ling-Wei Hsin;Chern J.-W.; Liu J.-R.; Yu C.-W.; Hung P.-Y.; LING-WEI HSIN; Chern J.-W. |
| 臺大學術典藏 |
2021-07-07T05:13:01Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng C.; Li Y.-H.; Yu C.-W.; Cheng Z.-H.; Liu J.-R.; Hsu J.-L.; LING-WEI HSIN; Huang C.-T.; Juan H.-F.; Chern J.-W.; Cheng Y.-S. |
| 臺大學術典藏 |
2021-07-05T07:59:45Z |
A newly designed molecule J2326 for Alzheimer's disease disaggregates amyloid fibrils and induces neurite outgrowth
|
Chang P.-T.; Talekar R.S.; FAN-LU KUNG; Chern T.-R.; Huang C.-W.; Ye Q.-Q.; Yang M.-Y.; Yu C.-W.; Lai S.-Y.; Deore R.R.; Lin J.-H.; Chen C.-S.; Chen G.S.; Chern J.-W. |
| 臺大學術典藏 |
2021-05-28T02:07:26Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng, C., Li, Y,.-H. Yu, C.-W., Cheng, J.-H., Liu, J.-R., Hsu, J.-L., Hsin, L.-W., Huang, C.-T.,?Juan, H.-F., Chern, J.-W., Cheng, Y.-S.; Peng, C.; Li, Y.-H.; Yu, C.-W.; Cheng, J.-H.; Liu, J.-R.; Hsu, J.-L.; Hsin, L.-W.; Huang, C.-T.; Juan, H.-F.; Chern, J.-W.; Cheng, Y.-S. |
| 臺大學術典藏 |
2021-05-24T06:35:21Z |
High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
|
Liu, J.-R.;Yu, C.-W.;Hung, P.-Y.;Hsin, L.-W.;Chern, J.-W.; Liu, J.-R.; Yu, C.-W.; Hung, P.-Y.; Hsin, L.-W.; Chern, J.-W.; JE-RUEI LIU |
| 臺大學術典藏 |
2021-05-21T01:54:02Z |
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity
|
Peng C.; Li, Y.H.; Yu, C.W.; Cheng, Z.H.; Liu, J.R.; Hsu, J.L.; Hsin, L.W.; Huang, C.T.; Juan, H.F.; Chern, J.W.; Cheng, Y.S. |
| 臺大學術典藏 |
2021-05-19T01:57:27Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; Chou W.-C.; SZU-CHUN HSU; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-03-18T03:23:35Z |
A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer
|
Chen B.-B.; Lu Y.-S.; Lin C.-H.; WEI-WU CHEN; Wu P.-F.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-03-18T03:23:33Z |
Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer
|
Chen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; WEI-WU CHEN; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-03-09T05:18:35Z |
Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
|
Hsu C.-Y.; Ying-Chun Shen; Yu C.-W.; Hsu C.; Hu F.-C.; Hsu C.-H.; Chen B.-B.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:44Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Shih T.T.-F.;Hou H.-A.;Liu C.-Y.;Chen B.-B.;Tang J.-L.;Chen H.-Y.;Wei S.-Y.;Yao M.;Huang S.-Y.;Wen-Chien Chou;Hsu S.-C.;Tsay W.;Yu C.-W.;Hsu C.-Y.;Tien H.-F.;Yang P.-C.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; WEN-CHIEN CHOU; Hsu S.-C.; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. |
| 臺大學術典藏 |
2021-02-05T06:29:40Z |
Dynamic contrast-enhanced MR imaging measurement of vertebral bone marrow perfusion may be indicator of outcome of acute myeloid leukemia patients in remission
|
Chen B.-B.;Hsu C.-Y.;Yu C.-W.;Hou H.-A.;Liu C.-Y.;Wei S.-Y.;Wen-Chien Chou;Tien H.-F.;Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Hou H.-A.; Liu C.-Y.; Wei S.-Y.; WEN-CHIEN CHOU; Tien H.-F.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-02-04T07:07:17Z |
The bioavailability and potential ecological risk of copper and zinc in river sediment are affected by seasonal variation and spatial distribution
|
Huang, C.-W.;Chai, Z.Y.;Yen, P.-L.;How, C.M.;Yu, C.-W.;Chang, C.-H.;Liao, V.H.-C.; Huang, C.-W.; Chai, Z.Y.; Yen, P.-L.; How, C.M.; Yu, C.-W.; Chang, C.-H.; Liao, V.H.-C.; VIVIAN LIAO |
| 臺大學術典藏 |
2021-02-02T06:40:57Z |
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F. |
| 臺大學術典藏 |
2021-02-02T06:40:56Z |
Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Kao J.-H.; Lee, Hsuan-Shu; Shih T.T.-F. |
| 臺大學術典藏 |
2021-02-02T06:40:54Z |
Hepatic necro-inflammation and elevated liver enzymes: Evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients
|
Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee, Hsuan-Shu; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee, Hsuan-Shu; Liang P.-C.; Wei S.-Y.; Hwang R.-M.; Shih T.T.-F. |
| 臺大學術典藏 |
2021-02-02T06:40:54Z |
Vascular and hepatic enhancements at MR imaging: Comparison of Gd-EOB-DTPA and Gd-DTPA in the same subjects
|
Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee, Hsuan-Shu; Liang P.-C.; Wei S.-Y.; Shih T.T.F.; Lin Y.-H.; Hwang R.-M.; Chen B.-B.; Hsu C.-Y.; Yu C.-W.; Kao J.-H.; Lee, Hsuan-Shu; Liang P.-C.; Wei S.-Y.; Shih T.T.F. |
| 臺大學術典藏 |
2021-01-12T12:49:20Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Yang P.-C.; Hsu C.-Y.; Tien H.-F.; Yu C.-W.; Tsay W.; Hsu S.-C.; Chou W.-C.; SHANG-YI HUANG; Yao M.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:44Z |
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival
|
Tien H.-F.; Yang P.-C.; Hsu C.-Y.; Yu C.-W.; Tsay W.; Hsu S.-C.; Chou W.-C.; Huang S.-Y.; Yao M.; Wei S.-Y.; Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; JIH-LUH TANG; Chen H.-Y. |
